We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Smart Pills Market Worth USD 3 Billion by 2025

By HospiMedica International staff writers
Posted on 16 Jan 2018
Print article
The global smart pills market was valued at USD 779.4 million in 2016 and is expected to grow at a CAGR of 15.5% during the forecast period (2017-2025) to reach USD 3.0 billion by 2025, driven by the increased prevalence of colorectal cancer and gastrointestinal disorders, geographical expansion by the major players, rising cancer screening awareness programs and faster FDA approvals.

These are the latest findings of Grand View Research, Inc. (San Francisco, CA, USA), a market research and consulting company.

The geriatric population, immobile patients, and patients with paralysis are the major consumers of smart pills. Smart pills are used mainly for screening and treatment of diseases, such as colorectal cancer, gastroparesis, gastric ulcers, and gastroesophageal disorders. As a result, capsule endoscopy is expected to be the largest application segment of the global smart pills market due to the increase in cancer screening awareness programs, rising incidence of Crohn's disease and bowel cancer, and higher demand for minimally invasive procedures. Capsule endoscopy is expected to replace traditional endoscopy methods due to its advantages, such as ease of administration and detailed observation of the gastrointestinal tract.

Regionally, North America dominates the global smart pills market with the largest revenue share of 57.1% in 2016 due to the wide availability of products, favorable reimbursement policies, rise in government healthcare investments, and increase in healthcare expenditure in the region. However, Asia Pacific is expected to be the world’s fastest-growing market for smart pills during the forecast period, led by a rise in disposable income, mandatory healthcare insurance, and increased healthcare expenditure in the region. Japan, China, and India are expected to be the key markets for smart pills in the Asia Pacific region.

Being a new technology, there have been limited product approvals so far and even fewer products are commercially available. However, the market players are studying a large number of smart pills for their potential use in diagnosis and in therapeutics of various chronic and acute diseases. The smart pills market is dominated by a limited number of players. The established players in the smart pills market are expanding their portfolio by upgrading their existing devices, whereas the new players are focusing on capturing the market in the emerging economies by launching breakthrough products, such as video endoscopy capsules, at affordable prices.

Related Links:
Grand View Research

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
12-Channel ECG
CM1200B
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Bronchoscope
EB-500

Print article

Channels

Critical Care

view channel
Image: A demonstration of the on-skin wearable bioelectronic device (Photo courtesy of University of Missouri)

On-Skin Wearable Bioelectronic Device Paves Way for Intelligent Implants

A team of researchers at the University of Missouri (Columbia, MO, USA) has achieved a milestone in developing a state-of-the-art on-skin wearable bioelectronic device. This development comes from a lab... Read more

Surgical Techniques

view channel
Image: The hyperspectral imaging system extracts molecular vibrations of different resins and distinguishes between them with high reproducibility (Photo courtesy of Hiroshi Takemura from Tokyo University of Science)

Novel Rigid Endoscope System Enables Deep Tissue Imaging During Surgery

Hyperspectral imaging (HSI) is an advanced technique that captures and processes information across a given electromagnetic spectrum. Near-infrared hyperspectral imaging (NIR-HSI) has particularly gained... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more